Insulet Corporation (PODD) Q3 2022 Earnings Call Transcript

Insulet Corporation (NASDAQ:PODD) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET

Company Participants

Deborah Gordon - Vice President, Investor Relations

Jim Hollingshead - President and Chief Executive Officer

Wayde McMillan - Executive Vice President and Chief Financial Officer

Bret Christensen - Executive Vice President and Chief Commercial Officer

Conference Call Participants

Jeff Johnson - Baird

Travis Steed - Bank of America Securities

Robbie Marcus - JPMorgan

Margaret Kaczor - William Blair

Larry Biegelsen - Wells Fargo

Caitlyn Cronin - Canaccord Genuity

Jayson Bedford - Raymond James

Steve Lichtman - Oppenheimer

Chris Pasquale - Nephron Research

Marie Thibault - BTIG

Matthew O'Brien - Piper Sandler

Matt Miksic - Barclays

Operator

Good afternoon, ladies and gentlemen and welcome to the Insulet Corporation Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Deborah Gordon, Vice President of Investor Relations.

Deborah Gordon

Thank you, Dilem. Good afternoon, and thank you for joining us for Insulet's third quarter 2022 earnings call. With me today are; Jim Hollingshead, President and Chief Executive Officer; and Wayde McMillan, Executive Vice President and Chief Financial Officer; Bret Christensen, our Executive Vice President and Chief Commercial Officer, is also with us today for the Q&A portion of our call. Both the replay of this call and the press release discussing our 2022 third quarter results and 2022 guidance will be available on the Investor Relations section of our website.

Before we begin, I would like to inform you that certain statements made by Insulet during the course of this call may be forward-looking, and could materially differ from current expectations. Please refer to the cautionary statements in our SEC filings for a detailed explanation of the inherent limitations of such statements.

We’ll also discuss non-GAAP financial measures with respect to our performance, namely adjusted operating margin, adjusted EBITDA and constant currency revenue, which is revenue growth, excluding the effect of foreign exchange. These measures align with what management uses as supplemental measures in assessing our operating performance, and we believe they are helpful to investors, analysts and other interested parties as measures of our operating performance from period to period.